These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7917909)

  • 1. Tumour tropism and anti-cancer efficacy of polymer-based doxorubicin prodrugs in the treatment of subcutaneous murine B16F10 melanoma.
    Seymour LW; Ulbrich K; Steyger PS; Brereton M; Subr V; Strohalm J; Duncan R
    Br J Cancer; 1994 Oct; 70(4):636-41. PubMed ID: 7917909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PDEPT: polymer-directed enzyme prodrug therapy. 2. HPMA copolymer-beta-lactamase and HPMA copolymer-C-Dox as a model combination.
    Satchi-Fainaro R; Hailu H; Davies JW; Summerford C; Duncan R
    Bioconjug Chem; 2003; 14(4):797-804. PubMed ID: 12862433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gamma scintigraphy of the biodistribution of 123I-labelled N-(2-hydroxypropyl)methacrylamide copolymer-doxorubicin conjugates in mice with transplanted melanoma and mammary carcinoma.
    Pimm MV; Perkins AC; Strohalm J; Ulbrich K; Duncan R
    J Drug Target; 1996; 3(5):375-83. PubMed ID: 8866656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PDEPT: polymer-directed enzyme prodrug therapy. I. HPMA copolymer-cathepsin B and PK1 as a model combination.
    Satchi R; Connors TA; Duncan R
    Br J Cancer; 2001 Sep; 85(7):1070-6. PubMed ID: 11592781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Starlike vs. classic macromolecular prodrugs: two different antibody-targeted HPMA copolymers of doxorubicin studied in vitro and in vivo as potential anticancer drugs.
    Jelínková M; Strohalm J; Etrych T; Ulbrich K; Ríhová B
    Pharm Res; 2003 Oct; 20(10):1558-64. PubMed ID: 14620507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gamma scintigraphy of a 123I-labelled N-(2-hydroxypropyl)methacrylamide copolymer-doxorubicin conjugate containing galactosamine following intravenous administration to nude mice bearing hepatic human colon carcinoma.
    Pimm MV; Perkins AC; Strohalm J; Ulbrich K; Duncan R
    J Drug Target; 1996; 3(5):385-90. PubMed ID: 8866657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HPMA copolymer platinates as novel antitumour agents: in vitro properties, pharmacokinetics and antitumour activity in vivo.
    Gianasi E; Wasil M; Evagorou EG; Keddle A; Wilson G; Duncan R
    Eur J Cancer; 1999 Jun; 35(6):994-1002. PubMed ID: 10533484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymeric drug-carriers containing doxorubicin and melanocyte-stimulating hormone: in vitro and in vivo evaluation against murine melanoma.
    O'Hare KB; Duncan R; Strohalm J; Ulbrich K; Kopeckova P
    J Drug Target; 1993; 1(3):217-29. PubMed ID: 8069563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor activity of N-(2-hydroxypropyl) methacrylamide copolymer-Mesochlorine e6 and adriamycin conjugates in combination treatments.
    Shiah JG; Sun Y; Peterson CM; Straight RC; Kopecek J
    Clin Cancer Res; 2000 Mar; 6(3):1008-15. PubMed ID: 10741728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between linear and star-like HPMA conjugated pirarubicin (THP) in pharmacokinetics and antitumor activity in tumor bearing mice.
    Nakamura H; Koziolová E; Etrych T; Chytil P; Fang J; Ulbrich K; Maeda H
    Eur J Pharm Biopharm; 2015 Feb; 90():90-6. PubMed ID: 25460144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New HPMA copolymer-based drug carriers with covalently bound hydrophobic substituents for solid tumour targeting.
    Chytil P; Etrych T; Konák C; Sírová M; Mrkvan T; Boucek J; Ríhová B; Ulbrich K
    J Control Release; 2008 Apr; 127(2):121-30. PubMed ID: 18304673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigating the mechanism of enhanced cytotoxicity of HPMA copolymer-Dox-AGM in breast cancer cells.
    Greco F; Vicent MJ; Gee S; Jones AT; Gee J; Nicholson RI; Duncan R
    J Control Release; 2007 Jan; 117(1):28-39. PubMed ID: 17129632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment with HPMA copolymer-based doxorubicin conjugate containing human immunoglobulin induces long-lasting systemic anti-tumour immunity in mice.
    Sirova M; Strohalm J; Subr V; Plocova D; Rossmann P; Mrkvan T; Ulbrich K; Rihova B
    Cancer Immunol Immunother; 2007 Jan; 56(1):35-47. PubMed ID: 16636810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biodistribution of free and N-(2-hydroxypropyl)methacrylamide copolymer-bound mesochlorin e(6) and adriamycin in nude mice bearing human ovarian carcinoma OVCAR-3 xenografts.
    Shiah JJ; Sun Y; Peterson CM; Kopecek J
    J Control Release; 1999 Aug; 61(1-2):145-57. PubMed ID: 10469911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HPMA copolymers platinates containing dicarboxylato ligands. Preparation, characterisation and in vitro and in vivo evaluation.
    Gianasi E; Buckley RG; Latigo J; Wasil M; Duncan R
    J Drug Target; 2002 Nov; 10(7):549-56. PubMed ID: 12683722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel α
    Wang F; Li L; Sun W; Li L; Liu Y; Huang Y; Zhou Z
    J Drug Target; 2018 Mar; 26(3):231-241. PubMed ID: 28792244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination chemotherapy and photodynamic therapy with N-(2-hydroxypropyl) methacrylamide copolymer-bound anticancer drugs inhibit human ovarian carcinoma heterotransplanted in nude mice.
    Peterson CM; Lu JM; Sun Y; Peterson CA; Shiah JG; Straight RC; Kopecek J
    Cancer Res; 1996 Sep; 56(17):3980-5. PubMed ID: 8752167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyacetal-doxorubicin conjugates designed for pH-dependent degradation.
    Tomlinson R; Heller J; Brocchini S; Duncan R
    Bioconjug Chem; 2003; 14(6):1096-106. PubMed ID: 14624622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biodistribution and pharmacokinetics of colon-specific HPMA copolymer--9-aminocamptothecin conjugate in mice.
    Gao SQ; Lu ZR; Kopecková P; Kopecek J
    J Control Release; 2007 Feb; 117(2):179-85. PubMed ID: 17150276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a macromolecular prodrug for the treatment of inflammatory arthritis: mechanisms involved in arthrotropism and sustained therapeutic efficacy.
    Quan LD; Purdue PE; Liu XM; Boska MD; Lele SM; Thiele GM; Mikuls TR; Dou H; Goldring SR; Wang D
    Arthritis Res Ther; 2010; 12(5):R170. PubMed ID: 20836843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.